Patients with #HypertrophicCardiomyopathy and comorbid #OSA who use GLP-1 receptor agonists have a significantly lower risk for major adverse cardiovascular events.

Patients with #HypertrophicCardiomyopathy and comorbid #OSA who use GLP-1 receptor agonists have a significantly lower risk for major adverse cardiovascular events.
Breaking: Spanish researchers at CNIC have identified a shared molecular mechanism in hypertrophic cardiomyopathy th… #Cardiovascularresearch #Hypertrophiccardiomyopathy #Inheritedheartdisease #Molecularmechanism #Targetedtherapy #Cardiovascularresearch #Hypertrophiccardiomyopathy #Inheritedhea…
📘Read in #JEV📘Pharmacological Inhibition of Small Extracellular Vesicle Secretion by ALK5i SD-208 via Lysosomal Rerouting of CD63+ Compartments #extracellularvesicles #hypertrophiccardiomyopathy #vesicletrafficking #cardiacfibroblasts isevjournals.onlinelibrary.wiley.com/doi/epdf/10....